tiprankstipranks
Aarti Pharmalabs Limited (IN:AARTIPHARM)
:AARTIPHARM
India Market
AARTIPHARM
Aarti Pharmalabs Limited
RESEARCH TOOLSreports

Aarti Pharmalabs Limited (AARTIPHARM) Ratios

1 Followers

Aarti Pharmalabs Limited Ratios

IN:AARTIPHARM's free cash flow for Q2 2026 was ₹0.34. For the 2026 fiscal year, IN:AARTIPHARM's free cash flow was decreased by ₹ and operating cash flow was ₹0.12. See a summary of the company’s cash flow.
Ratios
TTM
Mar 25Mar 24Mar 23Mar 22
Liquidity Ratios
Current Ratio
 1.64 2.01 1.94 1.94 1.77
Quick Ratio
 0.87 1.12 1.01 0.93 0.95
Cash Ratio
 0.07 0.01 0.03 0.02 0.14
Solvency Ratio
 0.26 0.39 0.35 0.37 0.25
Operating Cash Flow Ratio
 0.12 0.50 0.31 0.42 -0.08
Short-Term Operating Cash Flow Coverage
 0.25 1.13 0.82 1.17 -0.13
Net Current Asset Value
₹ 1.07B₹ 4.06B₹ 5.21B₹ 4.77B₹ 3.75B
Leverage Ratios
Debt-to-Assets Ratio
 0.20 0.14 0.11 0.10 0.17
Debt-to-Equity Ratio
 0.32 0.21 0.16 0.14 0.25
Debt-to-Capital Ratio
 0.24 0.17 0.14 0.12 0.20
Long-Term Debt-to-Capital Ratio
 0.09 0.05 <0.01 <0.01 <0.01
Financial Leverage Ratio
 1.60 1.46 1.47 1.44 1.47
Debt Service Coverage Ratio
 0.80 1.21 1.09 1.18 0.47
Interest Coverage Ratio
 8.71 14.03 16.35 13.28 13.78
Debt to Market Cap
 0.10 0.06 0.06 0.09 0.13
Interest Debt Per Share
 76.71 48.52 33.37 26.08 38.99
Net Debt to EBITDA
 1.44 0.85 0.67 0.59 1.30
Profitability Margins
Gross Profit Margin
50.08%46.67%21.53%21.28%26.20%
EBIT Margin
17.71%18.32%17.50%14.49%13.06%
EBITDA Margin
23.24%22.43%21.53%17.70%16.60%
Operating Profit Margin
17.71%17.85%15.50%14.37%13.83%
Pretax Profit Margin
15.64%17.05%16.55%13.41%13.03%
Net Profit Margin
11.87%12.88%11.95%9.95%10.26%
Continuous Operations Profit Margin
11.87%12.88%11.95%9.95%10.26%
Net Income Per EBT
75.89%75.52%72.18%74.20%78.68%
EBT Per EBIT
88.31%95.56%106.75%93.30%94.27%
Return on Assets (ROA)
6.54%9.37%8.40%8.62%5.99%
Return on Equity (ROE)
10.84%13.69%12.34%12.42%8.82%
Return on Capital Employed (ROCE)
12.99%16.78%14.91%17.01%11.30%
Return on Invested Capital (ROIC)
8.46%11.19%9.42%11.16%7.21%
Return on Tangible Assets
6.78%9.71%8.66%8.79%6.06%
Earnings Yield
3.42%3.99%5.33%7.74%4.68%
Efficiency Ratios
Receivables Turnover
 3.83 3.67 3.42 4.26 3.06
Payables Turnover
 3.15 4.06 3.77 4.51 4.10
Inventory Turnover
 1.45 1.92 2.22 2.54 1.85
Fixed Asset Turnover
 1.15 1.50 1.64 1.97 1.26
Asset Turnover
 0.55 0.73 0.70 0.87 0.58
Working Capital Turnover Ratio
 6.98 3.21 2.99 3.85 5.33
Cash Conversion Cycle
 231.52 199.71 174.62 148.28 227.45
Days of Sales Outstanding
 95.40 99.47 106.85 85.70 119.21
Days of Inventory Outstanding
 252.03 190.15 164.70 143.50 197.27
Days of Payables Outstanding
 115.90 89.91 96.92 80.92 89.04
Operating Cycle
 347.43 289.62 271.54 229.20 316.49
Cash Flow Ratios
Operating Cash Flow Per Share
 10.99 36.56 23.87 27.60 -4.82
Free Cash Flow Per Share
 -12.89 -7.77 1.94 14.40 -20.40
CapEx Per Share
 23.88 44.34 21.93 13.20 15.58
Free Cash Flow to Operating Cash Flow
 -1.17 -0.21 0.08 0.52 4.23
Dividend Paid and CapEx Coverage Ratio
 0.42 0.76 1.00 1.82 -0.31
Capital Expenditure Coverage Ratio
 0.46 0.82 1.09 2.09 -0.31
Operating Cash Flow Coverage Ratio
 0.15 0.80 0.76 1.16 -0.13
Operating Cash Flow to Sales Ratio
 0.06 0.16 0.12 0.13 -0.04
Free Cash Flow Yield
-1.87%-1.03%0.43%5.22%-7.08%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 29.23 25.08 18.75 12.92 21.37
Price-to-Sales (P/S) Ratio
 3.47 3.23 2.24 1.29 2.19
Price-to-Book (P/B) Ratio
 3.05 3.43 2.31 1.60 1.88
Price-to-Free Cash Flow (P/FCF) Ratio
 -53.45 -96.96 231.51 19.16 -14.13
Price-to-Operating Cash Flow Ratio
 62.71 20.61 18.80 10.00 -59.77
Price-to-Earnings Growth (PEG) Ratio
 -2.69 0.98 1.55 0.22 >-0.01
Price-to-Fair Value
 3.05 3.43 2.31 1.60 1.88
Enterprise Value Multiple
 16.37 15.25 11.07 7.85 14.51
Enterprise Value
 68.50B 72.38B 43.29B 27.03B 28.70B
EV to EBITDA
 16.37 15.25 11.07 7.85 14.51
EV to Sales
 3.80 3.42 2.38 1.39 2.41
EV to Free Cash Flow
 -58.61 -102.70 246.40 20.72 -15.53
EV to Operating Cash Flow
 68.77 21.83 20.01 10.81 -65.68
Tangible Book Value Per Share
 213.09 208.39 185.35 167.38 150.32
Shareholders’ Equity Per Share
 225.72 219.44 193.85 171.97 152.99
Tax and Other Ratios
Effective Tax Rate
 0.24 0.24 0.28 0.26 0.21
Revenue Per Share
 198.62 233.24 200.30 214.64 131.53
Net Income Per Share
 23.58 30.04 23.93 21.35 13.49
Tax Burden
 0.76 0.76 0.72 0.74 0.79
Interest Burden
 0.88 0.93 0.95 0.93 1.00
Research & Development to Revenue
 0.00 0.02 <0.01 <0.01 <0.01
SG&A to Revenue
 0.07 0.08 <0.01 <0.01 <0.01
Stock-Based Compensation to Revenue
 0.00 0.00 <0.01 0.00 0.00
Income Quality
 0.34 1.22 1.00 0.96 -0.28
Currency in INR